These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 3014640
1. Mechanism of action of omeprazole. Wallmark B. Scand J Gastroenterol Suppl; 1986; 118():11-7. PubMed ID: 3014640 [Abstract] [Full Text] [Related]
4. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro. Wallmark B, Lorentzon P, Larsson H. Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109 [Abstract] [Full Text] [Related]
8. [Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition]. Lamers CB. Ned Tijdschr Geneeskd; 1985 Apr 13; 129(15):679-82. PubMed ID: 2986019 [No Abstract] [Full Text] [Related]
9. Effect of omeprazole on gastric secretion in H+,K+-ATPase and in pepsinogen-rich cell fractions from rabbit gastric mucosa. Fryklund J, Wallmark B, Larsson H, Helander HF. Biochem Pharmacol; 1984 Jan 15; 33(2):273-80. PubMed ID: 6322797 [Abstract] [Full Text] [Related]
10. The relationship between gastric acid secretion and gastric H+,K+-ATPase activity. Wallmark B, Larsson H, Humble L. J Biol Chem; 1985 Nov 05; 260(25):13681-4. PubMed ID: 2997178 [Abstract] [Full Text] [Related]
11. Studies on the mechanism of action of omeprazole. Keeling DJ, Fallowfield C, Milliner KJ, Tingley SK, Ife RJ, Underwood AH. Biochem Pharmacol; 1985 Aug 15; 34(16):2967-73. PubMed ID: 2992525 [Abstract] [Full Text] [Related]
12. Specific labelling of gastric H+,K+-ATPase by omeprazole. Fryklund J, Gedda K, Wallmark B. Biochem Pharmacol; 1988 Jul 01; 37(13):2543-9. PubMed ID: 2839196 [Abstract] [Full Text] [Related]
13. [Effect of a new antiulcer drug, leminoprazole, on the gastric mucosal H+,K(+)-ATPase activity in rats]. Matsukura H, Masuda M, Uchida A, Kamishiro T. Nihon Yakurigaku Zasshi; 1994 Aug 01; 104(2):91-100. PubMed ID: 7927073 [Abstract] [Full Text] [Related]
14. Animal pharmacodynamics of omeprazole. A survey of its pharmacological properties in vivo. Larsson H, Mattson H, Sundell G, Carlsson E. Scand J Gastroenterol Suppl; 1985 Aug 01; 108():23-35. PubMed ID: 3858975 [Abstract] [Full Text] [Related]
15. Irreversible inactivation of rat gastric (H+-K+)-ATPase in vivo by omeprazole. Im WB, Blakeman DP, Davis JP. Biochem Biophys Res Commun; 1985 Jan 16; 126(1):78-82. PubMed ID: 2982382 [Abstract] [Full Text] [Related]
16. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs. Uchiyama K, Wakatsuki D, Kakinoki B, Takeuchi Y, Araki T, Morinaka Y. J Pharm Pharmacol; 1999 Apr 16; 51(4):457-64. PubMed ID: 10385219 [Abstract] [Full Text] [Related]
17. Coupling of H(+)-K(+)-ATPase activity and glucose oxidation in gastric glands. Fryklund J, Gedda K, Scott D, Sachs G, Wallmark B. Am J Physiol; 1990 May 16; 258(5 Pt 1):G719-27. PubMed ID: 2159239 [Abstract] [Full Text] [Related]
18. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo. Kwon D, Chae JB, Park CW, Kim YS, Lee SM, Kim EJ, Huh IH, Kim DY, Cho KD. Arzneimittelforschung; 2001 May 16; 51(3):204-13. PubMed ID: 11304936 [Abstract] [Full Text] [Related]
19. Comparison of five antisecretory agents acting via gastric H+/K+-ATPase. Bastaki SM, Chandranath I, Garner A. J Physiol Paris; 2000 May 16; 94(1):19-23. PubMed ID: 10761684 [Abstract] [Full Text] [Related]
20. Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs. De Graef J, Woussen-Colle MC. Gastroenterology; 1986 Aug 16; 91(2):333-7. PubMed ID: 2873074 [Abstract] [Full Text] [Related] Page: [Next] [New Search]